Navigation Links
IRIDEX Announces Automatic Conversion of Series A Preferred Stock to Common Stock

MOUNTAIN VIEW, Calif., June 11, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has converted all outstanding shares of its Series A Preferred Stock into 1,000,000 shares of its common stock. The Series A Preferred shares were issued to BlueLine Capital Partners LP (BlueLine) as part of a private placement agreement that occurred in 2007. The Certificate of Designation provides that the Series A Preferred shares will automatically convert into common stock if IRIDEX common stock trades above $5.00 for 30 consecutive trading days.

"This is a positive development for the Company and has been a goal since BlueLine invested in IRIDEX in a private placement and the preferred shares were issued in 2007," Will Moore President and CEO of IRIDEX said. "I want to thank BlueLine for their initial and ongoing support that has allowed us to get to this point. The conversion simplifies our capital structure, is non-dilutive and is an indication that we have made great strides in the past year in meeting commercial and operational milestones and winning investor confidence. The Series A Preferred Stock has always been included in the diluted share count and will be part of the basic and diluted share count going forward."

As a result of the conversion, the separate right of the holders of Series A Preferred Stock to a senior liquidation preference and to appoint a second board member, subject to the approval of the Company, have also ceased.


IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the markets for the Company's common stock.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended December 29, 2012, and our Quarterly Report on Form 10-Q for the fiscal quarter ended March 30, 2013, each of which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit
2. IRIDEX Reports 2013 First Quarter Results
3. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
4. IRIDEX Announces First Quarter 2013 Conference Call and Release Date
5. IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd.
6. IRIDEX Reports Record 2012 Fourth Quarter Results
7. IRIDEX Announces Fourth Quarter and Full Year 2012
8. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
9. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
10. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
11. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
Post Your Comments:
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
(Date:6/23/2016)... Research and Markets has announced the addition ... States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, ... Surgical Procedure Volumes: Global ... surgical procedure volume data in a geographic context. The ... of growth drivers and inhibitors, including world population growth, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):